Preferred Label : Atezolizumab/Carboplatin/Nab-paclitaxel Followed by Atezolizumab Regimen;
NCIt definition : A regimen consisting of atezolizumab, carboplatin and nab-paclitaxel followed by atezolizumab
that can be used for the treatment of non-small cell lung cancer (NSCLC).;
Origin ID : C210781;
chemotherapy_regimen_has_component
concept_is_in_subset